Definium Therapeutics DFTX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$6.48M (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 33.6% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 6.68% to 7.16% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +4,272,378 | 6.6% |
| Capital Research | Mutual Fund | 2026/Q3 | +2,905,074 | 8.2% |
| Barclays PLC | Public Company | 2026/Q3 | +547,966 | 0.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +539,761 | 8.6% |
| Ensign Peak Advisors Inc. | Endowment Fund | 2026/Q3 | +447,626 | 0.7% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +429,202 | 0.8% |
| Lord, Abbett & Co. LLC | Mutual Fund | 2026/Q3 | +539,476 | 0.4% |
| Capital Research | Mutual Fund | 2026/Q3 | +8,331,133 | 6.2% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +4,582,031 | 3.4% |
| FMR | Mutual Fund | 2026/Q3 | +2,943,158 | 3.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +2,752,604 | 8.4% |
| Avoro Capital Advisors LLC | Hedge Fund | 2026/Q3 | +2,188,888 | 5.3% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +2,059,604 | 4.1% |
| AllianceBernstein | Mutual Fund | 2026/Q3 | +1,711,584 | 1.3% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +1,644,985 | 2.2% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 24 Sep 2026 | Mark Sullivan | Chief Legal Officer | Automatic Disposition | -14,051 | $36.57 | 253,603 |
| 24 Sep 2026 | Brandi Roberts | Chief Financial Officer | Automatic Disposition | -3,377 | $36.57 | 263,278 |
| 24 Sep 2026 | Matthew Wiley | Chief Commercial Officer | Automatic Disposition | -3,097 | $36.57 | 8,411 |
| 24 Sep 2026 | Robert Barrow | Chief Executive Officer | Automatic Disposition | -31,550 | $36.57 | 444,340 |
| 24 Sep 2026 | Daniel Karlin | Chief Medical Officer | Automatic Disposition | -10,853 | $36.57 | 574,096 |
| 17 Sep 2026 | Carol Vallone | Independent Chairperson | Derivative Exercise and Retained | +1,086 | $35.52 | 18,797 |
| 17 Sep 2026 | Andreas Krebs | Independent Vice Chairperson | Derivative Exercise and Retained | +1,629 | $35.52 | 17,903 |
| 13 Sep 2026 | Mark Sullivan | Chief Legal Officer | Other Acquisition | +125,000 | – | 267,654 |
| 13 Sep 2026 | Brandi Roberts | Chief Financial Officer | Other Acquisition | +125,000 | – | 266,655 |
| 13 Sep 2026 | Matthew Wiley | Chief Commercial Officer | Other Acquisition | +125,000 | – | 362,133 |
| 13 Sep 2026 | Robert Barrow | Chief Executive Officer | Other Acquisition | +750,000 | – | 1,768,750 |
| 13 Sep 2026 | Daniel Karlin | Chief Medical Officer | Other Acquisition | +200,000 | – | 584,949 |
| 2 Sep 2026 | Robert Barrow | Chief Executive Officer | Automatic Disposition | -19,023 | $37.94 | 450,890 |
| 1 Sep 2026 | Robert Barrow | Chief Executive Officer | Other Acquisition | +40,000 | – | 450,890 |
| 11 Aug 2026 | Mark Sullivan | Chief Legal Officer | Other Acquisition | +62,500 | – | 125,259 |
| 11 Aug 2026 | Brandi Roberts | Chief Financial Officer | Other Acquisition | +62,500 | – | 131,362 |
| 11 Aug 2026 | Matthew Wiley | Chief Commercial Officer | Other Acquisition | +62,500 | – | 237,133 |
| 11 Aug 2026 | Robert Barrow | Chief Executive Officer | Other Acquisition | +375,000 | – | 1,065,625 |
| 11 Aug 2026 | Daniel Karlin | Chief Medical Officer | Other Acquisition | +100,000 | – | 603,282 |
| 24 Jun 2026 | Mark Sullivan | Chief Legal Officer | Automatic Disposition | -13,008 | $45.03 | 23,698 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 9,613,993 | 7.2% | 5.8 |
| 15 Oct 2026 | 10,044,279 | 7.5% | 4.9 |
| 30 Sep 2026 | 11,344,959 | 8.4% | 4.9 |
| 15 Sep 2026 | 11,785,195 | 8.8% | 5.2 |
| 31 Aug 2026 | 9,836,400 | 7.3% | 5.6 |
| 14 Aug 2026 | 8,969,420 | 6.7% | 3.4 |
No comments yet — be the first to weigh in on DFTX.
Sign in to join the discussion.